Add Company
Join Now

CUTISS’ Revenue and Competitors

License our Company Data API

Location

N/A

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • CUTISS’'s estimated annual revenue is currently $8.5M per year.(i)
  • CUTISS’'s estimated revenue per employee is $149,561

Employee Data

  • CUTISS’ has 57 Employees.(i)
  • CUTISS’ grew their employee count by 27% last year.

CUTISS’'s People

NameTitleEmail/Phone
1
Director Quality ControlReveal Email/Phone
2
Finance ManagerReveal Email/Phone
3
Quality Control AssociateReveal Email/Phone
4
GMP Manufacturing AssociateReveal Email/Phone
5
GMP Manufacturing AssociateReveal Email/Phone
6
GMP manufacturing associateReveal Email/Phone
7
Senior Research AssociateReveal Email/Phone
8
Operations SpecialistReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$8.5M5727%N/AN/A
#2
$8.4M5218%N/AN/A
Add Company

What Is CUTISS’?

Our Solution – Personalized, bio-engineered, dermo-epidermal skin grafts After more than 15 years of research (Tissue Biology Research Unit, University Children's Hospital Zurich), CUTISS AG can now bio-engineer large quantities of individually customized human skin grafts, denovoSkin™, starting off from a very small piece of healthy patient's skin. Because of its intrinsic characteristics, denovoSkin™ is expected to result in a minimally scarring outcome after transplantation. denovoSkin™ received a Swissmedic, EMA and FDA Orphan drug designation for the treatment of burns. Since 2016, CUTISS is supported by WYSS ZURICH, that finances the clinical trial programs and offers the manufacturing facility for DenovoSkin.

keywords:N/A

N/A

Total Funding

57

Number of Employees

$8.5M

Revenue (est)

27%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
N/A5730%N/A
#2
$7.3M5816%N/A
#3
$7.4M597%N/A
#4
N/A5984%N/A
#5
$13.7M60-5%N/A